AB0428 Preferences in the use of biologic drugs and adverse events in patients with rheumatic disease from a national biologics registry in mÉxico
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.4832
Abstract: Background National registries of biologic drugs have proven to be valuable tools in following patients with rheumatic disease and some outcomes in real-life situations. Objectives The objective of this study was to describe Mexican Rheumatologists’… read more here.
Keywords: treatment; biologic drugs; speakers bureau; pfizer bms ... See more keywords